Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07397780 · ClinicalTrials.gov registry record
RPMO2 Oximeter Accuracy During Sleep 1 Trial
A clinical trial of Obstructive Sleep Apnea, sponsored by ProSomnus Sleep Technologies.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07397780 is a study of Obstructive Sleep Apnea that is active but no longer recruiting, run by ProSomnus Sleep Technologies. The registered enrollment target is 30 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07397780, a study of Obstructive Sleep Apnea, is active but no longer recruiting, sponsored by ProSomnus Sleep Technologies.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to validate the accuracy of the RPMO2 OSA Device's oxygen desaturation index in individuals with obstructive sleep apnea versus the gold standard, in-lab polysomnography. Participants will receive an RPMO2 OSA Device and complete one night in a sleep lab using the device in addition to the standard montage used for polysomnography.
Conditions Studied
Interventions
- DEVICE RPMO2 OSA Device
Study Locations (1)
Texas
- Star Sleep and Wellness - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-01-22 |
| Est. Completion | 2026-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07397780
The ClinicalTrials.gov registry entry for NCT07397780 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (86% lower). The listed sponsor is ProSomnus Sleep Technologies, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which RPMO2 OSA Device is the first listed.
NCT07397780 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07397780 about?
NCT07397780 is a clinical study titled "RPMO2 Oximeter Accuracy During Sleep 1 Trial". The goal of this observational study is to validate the accuracy of the RPMO2 OSA Device's oxygen desaturation index in individuals with obstructive sleep apnea versus the gold standard, in-lab polysomnography. Participants will receive an RPMO2 OSA Device and complete one night in a sleep lab usin...
What is the current status of trial NCT07397780?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2026-01-22. Estimated completion is 2026-07-30.
What conditions does trial NCT07397780 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT07397780?
The interventions under investigation include: RPMO2 OSA Device (DEVICE).
Who is sponsoring clinical trial NCT07397780?
This trial is sponsored by ProSomnus Sleep Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07397780 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
RECRUITING · Phase 1
-
Effect of CPAP on Blood Pressure in Excessively Sleepy Obstructive Sleep Apnea Subtype
RECRUITING
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Patient-centered and Neurocognitive Outcomes with Acetazolamide for Sleep Apnea
RECRUITING · Phase 2
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.